Epigenetic alternations related to ischemic stroke-a case-control study

Epigenetic alternations of microRNAs and DNA methylation contribute to ischemic stroke

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044611

Enrollment

Unknown

Registered

2021-03-24

Start date

2021-03-31

Completion date

Unknown

Last updated

2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with suspected IS were recruited within 24 hours of symptom onset. All patients had a final diagnosis of IS as defined by an acute focal neurological deficit in combination with a diffusion weighted imaging–positive lesion on magnetic resonance imaging or a new lesion on a delayed CT scan.

Exclusion criteria

Exclusion criteria: Patients with infection (current or within 2 weeks of stroke), immunosuppressive therapy, lymphoma, leukemia, or treatment with thrombolytic therapy were excluded from study.

Design outcomes

Primary

Measure	Time frame
hub gene, DNA methylation and miRNA;	—

Countries

China

Contacts

Public ContactLi Yan

Department of Anesthesiology, the Fourth Affiliated Hospital, Harbin Medical University

liyan_8809@126.com+86 15804626875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026